Combining Functional Design of Experiments (DOE) with traditional DOE creates a robust framework to enhance production by addressing time-based variations and complex cell culture interactions. This approach improves understanding of critical parameters, optimizing production, product quality, and process efficiency.
The integration of predictive modeling into bioprocess automation and control systems is transforming the biopharmaceutical industry. Experience the transformative power of predictive modeling and digital twin technology to optimize bioprocess efficiency, ensure product quality, and drive innovation in biopharmaceutical manufacturing.
From a more proactive (and optimistic) point of view, utilizing innovation in biopharmaceutical digital integration and data analytics affords us a very real opportunity to improve our manufacturing processes and the quality of our decision making, especially as we navigate a radically and rapidly changing landscape.
Samsung Biologics is a fully integrated, end-to-end CDMO service provider offering seamless development and manufacturing solutions from cell line development to final aseptic fill/finish for biologics. With commercialization in mind, we expand our development portfolio and continue to offer better service to fit clients' needs. Our facilities are cGMP compliant with bioreactor sizes ranging from small to large scale, enabling us to better serve the various needs of our clients and to meet growing biomanufacturing demands.
